Drug Information

Drug General Information
Drug ID
D0C6ID
Former ID
DIB015851
Drug Name
Citatuzumab bogatox
Synonyms
VB6-845; Antibody therapeutic (ovary tumor), Viventia; Ovary cancer therapeutic (antibody), Viventia; Anti-EpCAM-bouganin conjugate (anticancer), Viventia
Drug Type
Antibody
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [522038]
Company
Viventia Biotech Inc
CAS Number
CAS 945228-49-9
Target and Pathway
Target(s) Tumor-associated calcium signal transducer 1 Target Info [531988]
References
Ref 522038ClinicalTrials.gov (NCT00481936) Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin. U.S. National Institutes of Health.
Ref 531988Preclinical evaluation of VB6-845: an anti-EpCAM immunotoxin with reduced immunogenic potential. Cancer Biother Radiopharm. 2012 Nov;27(9):582-92.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.